0001209191-15-029798.txt : 20150327 0001209191-15-029798.hdr.sgml : 20150327 20150327143019 ACCESSION NUMBER: 0001209191-15-029798 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20150317 FILED AS OF DATE: 20150327 DATE AS OF CHANGE: 20150327 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ignyta, Inc. CENTRAL INDEX KEY: 0001557421 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11095 FLINTKOTE AVE. STREET 2: SUITE D CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 255-5959 MAIL ADDRESS: STREET 1: 11095 FLINTKOTE AVE. STREET 2: SUITE D CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: Infinity Oil & Gas Co DATE OF NAME CHANGE: 20120913 FORMER COMPANY: FORMER CONFORMED NAME: Infinity Oill & Gas Co DATE OF NAME CHANGE: 20120904 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: TEVA PHARMACEUTICAL INDUSTRIES LTD CENTRAL INDEX KEY: 0000818686 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36344 FILM NUMBER: 15730472 BUSINESS ADDRESS: STREET 1: 5 BAZEL ST STREET 2: P O B 3190 CITY: PETACH TIKVA STATE: L3 ZIP: 49131 MAIL ADDRESS: STREET 1: TEVA PHARMACEUTICAL INDUSTRIES LIMITED STREET 2: 5 BAZEL ST PO B 3190 CITY: PETACH TIKVA STATE: L3 ZIP: 49131 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CEPHALON INC CENTRAL INDEX KEY: 0000873364 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36344 FILM NUMBER: 15730473 BUSINESS ADDRESS: STREET 1: 1090 HORSHAM ROAD CITY: NORTH WALES STATE: PA ZIP: 19454 BUSINESS PHONE: 215 591 3000 MAIL ADDRESS: STREET 1: 1090 HORSHAM ROAD CITY: NORTH WALES STATE: PA ZIP: 19454 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2015-03-17 0 0001557421 Ignyta, Inc. RXDX 0000873364 CEPHALON INC 1090 HORSHAM ROAD NORTH WALES PA 19454 0 0 1 0 0000818686 TEVA PHARMACEUTICAL INDUSTRIES LTD 5 BASEL STREET PO BOX 3190 PETACH TIKVA L3 4951033 ISRAEL 0 0 1 0 Common Stock 3000000 D Cephalon, Inc. is an indirect wholly owned subsidiary of Teva Pharmaceutical Industries Limited /s/ Austin D. Kim (Attorney in Fact, Cephalon, Inc.) 2015-03-26 /s/ Austin D. Kim (Attorney in Fact, Teva Pharmaceutical Industries Limited) 2015-03-26 EX-24 2 attachment1.htm EX-24 DOCUMENT
                           LIMITED POWER OF ATTORNEY


       The undersigned hereby constitutes and appoints each of Brian Shanahan
and Austin Kim, signing singly, and with full power of substitution, the
undersigned's true and lawful attorney-in-fact to:

       (1)    execute for and on behalf of the undersigned, in the undersigned's
capacity as a Section 16 reporting person of IGNYTA, INC. (the "Company"), from
time to time the following U.S. Securities and Exchange Commission ("SEC")
forms: (i) Form ID, including any attached documents, to effect the assignment
of codes to the undersigned to be used in the transmission of information to the
SEC using the EDGAR System; (ii) Form 3, Initial Statement of Beneficial
Ownership of Securities, including any attached documents;  (iii) Form 4,
Statement of Changes in Beneficial Ownership of Securities, including any
attached documents; (iv) Form 5, Annual Statement of Beneficial Ownership of
Securities in accordance with Section 16(a) of the Securities Exchange Act of
1934, as amended, and the rules thereunder, including any attached documents;
(v) Schedule 13D and (vi) amendments of each thereof, in accordance with the
Securities Exchange Act of 1934, as amended, and the rules thereunder, including
any attached documents;

       (2)    do and perform any and all acts for and on behalf of the
undersigned which may be necessary or desirable to complete and execute any such
Form 3, 4 or 5, Schedule 13D or any amendment(s) thereto, and timely file such
form(s) with the SEC and any securities exchange, national association or
similar authority; and

       (3)    take any other action of any type whatsoever in connection with
the foregoing which, in the opinion of such attorney-in-fact, may be of benefit
to, in the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and shall
contain such terms and conditions as such attorney-in-fact may approve in such
attorney-in-fact's discretion.

       The undersigned hereby grants to each such attorney-in-fact, acting
singly, full power and authority to do and perform any and every act and thing
whatsoever requisite, necessary or proper to be done in the exercise of any of
the rights and powers herein granted, as fully to all intents and purposes as
the undersigned might or could do if personally present, with full power of
substitution or revocation, hereby ratifying and confirming all that such
attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall
lawfully do or cause to be done by virtue of this power of attorney and the
rights and powers herein granted.  The undersigned acknowledges that the
foregoing attorneys-in-fact, in serving in such capacity at the request of the
undersigned, are not assuming, nor is the Company assuming, any of the
undersigned's responsibilities to comply with Section 16 or Regulation 13D-G of
the Securities Exchange Act of 1934, as amended.  The undersigned hereby agrees
to indemnify the attorney in fact and the Company from and against any demand,
damage, loss, cost or expense arising from any false or misleading information
provided by the undersigned to the attorney-in fact.

       This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file such forms with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact.



       IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
be executed as of March 26, 2015.


Date:  March 26, 2015                CEPHALON, INC.



                                     By:    /s/ Austin D. Kim
                                            -----------------------------
                                     Name:  Austin D. Kim
                                     Title: Assistant Secretary


Date:  March 26, 2015                TEVA PHARMACEUTICAL INDUSTRIES LIMITED


                                     By:    /s/ Eyal Desheh
                                            -----------------------------
                                     Name:  Eyal Desheh
                                     Title: Chief Financial Officer